Interface Engineering and Heteroatom Doping Trigger Multisite Synergism in V-Incorporated MoP/Cu 3 P to Accelerate Alkaline Hydrogen Evolution
ACS Sustainable Chemistry & Engineering · 11.08.2025 · 13 (31) · 12345-12357
DOI: 10.1021/acssuschemeng.5c02007 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sustainable Chemistry & Engineering, online erschienen am 31.07.2025. Verfasst von Xueting Li und 7 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Heilongjiang University, National Natural Science Foundation of China, Outstanding Young Teachers in Heilongjiang Provincial University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Heilongjiang University
- National Natural Science Foundation of China
- Outstanding Young Teachers in Heilongjiang Provincial University
- Heilongjiang Provincial Youth Science and Technology Talent Support Program
Zitieren
APA
Li, X., Wang, G., Lv, C., Wang, X., Liu, Y., Yan, H., Zhang, Z., & Jiao, Y. (2025). Interface Engineering and Heteroatom Doping Trigger Multisite Synergism in V-Incorporated MoP/Cu 3 P to Accelerate Alkaline Hydrogen Evolution. ACS Sustainable Chemistry & Engineering, 13(31), 12345-12357. https://doi.org/10.1021/acssuschemeng.5c02007
Vancouver
Li X, Wang G, Lv C, Wang X, Liu Y, Yan H, et al. Interface Engineering and Heteroatom Doping Trigger Multisite Synergism in V-Incorporated MoP/Cu 3 P to Accelerate Alkaline Hydrogen Evolution. ACS Sustainable Chemistry & Engineering. 2025;13(31):12345-12357. doi:10.1021/acssuschemeng.5c02007
BibTeX
@article{Li2025,
author = {Li, Xueting and Wang, Guimin and Lv, Chunmei and Wang, Xiuwen and Liu, Yue and Yan, Haijing and Zhang, Zilin and Jiao, Yanqing},
title = {Interface Engineering and Heteroatom Doping Trigger Multisite Synergism in V-Incorporated MoP/Cu 3 P to Accelerate Alkaline Hydrogen Evolution},
journal = {ACS Sustainable Chemistry & Engineering},
year = {2025},
volume = {13},
number = {31},
pages = {12345--12357},
doi = {10.1021/acssuschemeng.5c02007}
}
EUVIMED